Cartesian Therapeutics Inc. (RNAC) — Net Asset Quality Index
Cartesian Therapeutics Inc. (RNAC) has a Net Asset Quality Index of -9.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $372.68 Million minus total liabilities of $408.52 Million yields net assets of $-35.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Cartesian Therapeutics Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Cartesian Therapeutics Inc. Net Asset Quality Index Over Time (2014–2024)
This chart shows how Cartesian Therapeutics Inc.'s Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at -9.6%, representing net assets of $-35.84 Million against total assets of $372.68 Million USD. See working capital to net assets of Cartesian Therapeutics Inc. to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Cartesian Therapeutics Inc. (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Cartesian Therapeutics Inc. from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see RNAC company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -1.6% | $-6.80 Million | $435.02 Million | $441.82 Million | ▲ +142.7 pp |
| 2023 | -144.3% | $-440.18 Million | $305.05 Million | $745.23 Million | ▼ -200.9 pp |
| 2022 | 56.6% | $93.83 Million | $165.89 Million | $72.06 Million | ▲ +42.5 pp |
| 2021 | 14.1% | $22.52 Million | $159.88 Million | $137.36 Million | ▲ +25.0 pp |
| 2020 | -10.9% | $-18.01 Million | $165.44 Million | $183.44 Million | ▼ -19.3 pp |
| 2019 | 8.4% | $8.40 Million | $99.57 Million | $91.17 Million | ▲ +20.6 pp |
| 2018 | -12.2% | $-5.42 Million | $44.48 Million | $49.90 Million | ▼ -63.4 pp |
| 2017 | 51.3% | $51.81 Million | $101.10 Million | $49.29 Million | ▼ -10.3 pp |
| 2016 | 61.5% | $54.96 Million | $89.30 Million | $34.34 Million | ▲ +333.6 pp |
| 2015 | -272.0% | $-116.49 Million | $42.82 Million | $159.32 Million | ▲ +122.8 pp |
| 2014 | -394.8% | $-87.75 Million | $22.23 Million | $109.98 Million | — |